Do We Get Samples of the Report?

Yes, you will receive a sample copy of the market research report from the sales team when you put a query to us. The sample report is free and offers a brief view of the report and information on data available before you purchase the full-fledged report. Also, we will provide a demo sample for any oncoming study.

How to Buy a Market Report?

Select the report you wish to purchase and proceed to buy it by making an online payment. We use a secured gateway for payment transfers and do not share your financial information with any unconcerned third party.

In Which Format Will I Get the Report?

The report will be delivered in spreadsheet and PDF format. In some cases, PPT formats could be available as well.

In How Much Time I will Get the Report After Purchase?

After confirmation of the payment, you will receive the electronic format of the report at your registered email address in (mention the timeline for the delivery). If you buy a report over a holiday or weekend, we will process the request the next working day.

How Can I Get the Report Customized?

Market studies and reports already contain important data and are ready for distribution to the purchaser. However, if there is any particular query, addition, or customization you require, then contact us on our email id or phone. We will look to accommodate your request and see what can be done at the earliest. The research team will design the report accordingly and discuss the solutions beforehand with you.

How Much Will It Cost to Get a Report Customized?

The price of the customized report will be conveyed to you by our team after we agree on the deliverable. A delivery timeline will be set so that you get the report within the expected date. Any requests for customizations after selling the report will be handled by a separate department and the prices for the same mentioned upfront.

Can I Buy Only a Particular Segment of the Study?

While usually such a request is not accommodated as any market research report is wholesome and the cost of the report is for overall contents, in special cases, we may be able to sell select segments of the report based on your requirements.

Is There Any Available Discount?

Our team will love to support academicians, start-ups, students, and others with consulting and research. Thus, our pricing plan is based on keeping these interests in mind and is already affordable. However, we may have discounts available for particular customer types and reports. So, contact us for more information.

Which Services Are Complimentary Before Purchasing the Report?

We have consumer-centric reports and offer several facilities before selling. You will get a free review and sample report, talk to our customer care team for any additions to be done and meet special requirements, and interact with our analysts for deeper understanding.

Will I Receive a Bill or Invoice for the Report Purchased?

Yes, you will get an invoice for the purchase you made. The invoice will be sent to you electronically on your registered email id.

What If I am Unable to Find the Report in the Catalog?

We have a vast database of market reports and studies and there are a few which may not have been uploaded yet. If you are unable to find the one you want, then get in touch with our sales team by phone or email and we will connect with you for assistance.

How Often Are the Existing Studies Updated?

Not every study is the same. Thus, the update for reports will depend on the ongoing research and changes if any to be incorporated in the document or not.

What If the Report Does Not Contain the Information I Want?

The market research reports are constructed keeping in mind the industry trends, nature of the study, and required inputs. But if you want something more than what is stated in the report, we can help you out with further research if possible. Contact us right away, and we will do the needful to aid you.

Is the Payment Refundable?

Once the payment is done, it is non-refundable because as per the standard policy, the utility of the reports is based on knowledge sharing, and thus, a refund is not possible to make after we have issued you obtain the study. To avoid the hassle, we have a detailed view of the report and its ideas through a sample report.

What If the Payment Fails?

If the payment fails then be assured that you shall receive the money back to the source payment mode from the payment gateway. Aarkstore is not responsible for any loss of payment in the process.

Can I Avail the Report of a Particular Country/Region?

Yes, we can provide a report or segment related to a particular region or geography if we have that feature available for the document.

Do You Offer Support After Purchase?

Yes, we are here to solve any queries you may have for the report from our analyst till a given timeframe. To understand more about this, get in touch with us.

Athenex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DESCRIPTION

TABLE OF CONTENTS

RELATED REPORTS

SAMPLE REQUEST

REVIEWS

DESCRIPTION

Summary

Athenex Inc (Athenex), formerly Kinex Pharmaceuticals LLC is a drug manufacturing and distributing company that distributes therapies for cancer diseases and supportive therapies. The company offers drug discovery, drug formulation and clinical development. It offers products such as ointment formulation, oral formulation, oral absorption platform and symptom therapeutics. Athenex also provides transmucosal drug, active ingredients and intermediates, pharmaceutical and specialty chemicals, and in-vitro diagnostic devices. The company has its presence in the US and China. It partners with pharmaceutical companies, universities and research institutions located across Guangzhou, China; Dunedin, New Zealand; Taipei, Taiwan; Seoul, South Korea; and Guatemala City, Guatemala. Athenex is headquartered in Buffalo, New York, the US.

Athenex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

TABLE OF CONTENTS

2
List of Tables 4
List of Figures 5
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Athenex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Athenex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Athenex Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Athenex Raises USD38 Million in Financing 13
Kinex Pharma Raises USD74.4 Million in Venture Financing 13
Kinex Pharma Raises US$0.3 Million In Venture Financing 14
QuaDPharma Raises US$1 Million In Venture Financing 14
Kinex Pharma Raises Funds In First Tranche Of Financing Round 15
Kinex Pharma Raises US$5 Million In Venture Financing 16
Partnerships 17
Athenex Enters into Agreement with Imuna Pharm 17
Athenex Enters into Partnership with Eli Lilly and Company 17
Athenex to Form Joint Venture with SunGen Pharma 18
Athenex Enters into Agreement with Gland Pharma 18
Licensing Agreements 19
PharmaEssentia Amends its Licensing Agreement with Athenex for Oraxol and Oratecan 19
Hanmi Pharma Expands Licensing Agreement with Kinex Pharma for Orascovery Program 20
Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 21
Hanmi Pharma Expands Licensing Agreement With Kinex Pharma For Orascovery Program 22
Kinex Pharma Expands Licensing Agreement With Hanmi Pharma 23
Kinex Pharma Enters Into Licensing Agreement With Zenith For Oraxol And Oratecan 25
Kinex Pharma Enters Into Licensing Agreement With PharmaEssentia 26
Kinex Pharma Enters Into Licensing Agreement With Xiangxue Pharma For KX02 27
Kinex Pharma Enters Into Licensing Agreement With Hanmi Pharma 28
Kinex Pharma Enters Into Licensing Agreement With Hanmi Pharma For KX01 29
Equity Offering 30
Kinex Pharma Raises Funds through Private Placement of Shares 30
Kinex Pharma Completes Private Placement Of Shares For US$40 Million 31
Acquisition 32
Athenex Acquires Comprehensive Drug Enterprises 32
Kinex Pharma Acquires QuaDPharma, Contract Drug Company 33
Athenex Inc - Key Competitors 34
Key Employees 35
Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Strategy And Business Planning 38
Feb 11, 2016: Governor Cuomo Announces Major Expansion of Athenex -- Creating 1,400 Jobs in Western New York 38
Corporate Communications 41
Mar 01, 2017: Athenex announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer 41
Feb 27, 2017: Athenex appoints veteran J. Nick Riehle as Chief Financial Officer 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List Of Tables

Athenex Inc, Pharmaceuticals & Healthcare, Key Facts 1
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Athenex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Athenex Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Athenex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Athenex Raises USD38 Million in Financing 13
Kinex Pharma Raises USD74.4 Million in Venture Financing 13
Kinex Pharma Raises US$0.3 Million In Venture Financing 14
QuaDPharma Raises US$1 Million In Venture Financing 14
Kinex Pharma Raises Funds In First Tranche Of Financing Round 15
Kinex Pharma Raises US$5 Million In Venture Financing 16
Athenex Enters into Agreement with Imuna Pharm 17
Athenex Enters into Partnership with Eli Lilly and Company 17
Athenex to Form Joint Venture with SunGen Pharma 18
Athenex Enters into Agreement with Gland Pharma 18
PharmaEssentia Amends its Licensing Agreement with Athenex for Oraxol and Oratecan 19
Hanmi Pharma Expands Licensing Agreement with Kinex Pharma for Orascovery Program 20
Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 21
Hanmi Pharma Expands Licensing Agreement With Kinex Pharma For Orascovery Program 22
Kinex Pharma Expands Licensing Agreement With Hanmi Pharma 23
Kinex Pharma Enters Into Licensing Agreement With Zenith For Oraxol And Oratecan 25
Kinex Pharma Enters Into Licensing Agreement With PharmaEssentia 26
Kinex Pharma Enters Into Licensing Agreement With Xiangxue Pharma For KX02 27
Kinex Pharma Enters Into Licensing Agreement With Hanmi Pharma 28
Kinex Pharma Enters Into Licensing Agreement With Hanmi Pharma For KX01 29
Kinex Pharma Raises Funds through Private Placement of Shares 30
Kinex Pharma Completes Private Placement Of Shares For US$40 Million 31
Athenex Acquires Comprehensive Drug Enterprises 32
Kinex Pharma Acquires QuaDPharma, Contract Drug Company 33
Athenex Inc, Key Competitors 34
Athenex Inc, Key Employees 35
Athenex Inc, Subsidiaries 37

List Of Figures

Athenex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Athenex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

RELATED REPORTS

SAMPLE REQUEST

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

REVIEWS

There is no Reviews available

Search and Get the Latest Market Research Reports

Athenex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Athenex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Binx Health Inc - Product Pipeline Analysis, 2021 Update

Profound Medical Inc - Product Pipeline Analysis, 2021 Update

FAQs